Multichannel Immune Nanoregulators Suppress Lactic Acid Metabolism and Lactic Acid-Shaped Acidic Microenvironment to Uproot Anti-Tumor Immunosuppression
- PMID: 41001978
- DOI: 10.1002/adma.202512230
Multichannel Immune Nanoregulators Suppress Lactic Acid Metabolism and Lactic Acid-Shaped Acidic Microenvironment to Uproot Anti-Tumor Immunosuppression
Abstract
Lactic acid (LA) itself and the LA-shaped acidic tumor microenvironment (TME) are identified as root causes of cancer immunosuppression, and no effective strategies address them. Here a multichannel immune nanoregulator is engineered to dampen acidic TME and repolarize non-inflammatory macrophages to uproot this source of cancer immunosuppression, wherein fluorocarbon chains (FC)-modified mesoporous silica (FM) serves as nanoreactors and carriers to in situ synthesize CaO2 and load R848, respectively, followed by liposome coating, anti-CD105 modification and FC-mediated O2 binding in sequence. Both liposome shell and intraparticle FC ensure safe CaO2 delivery. Ultrasound-triggered FC-binding O2 burst and liposomes-destruction-enhanced CaO2 reactions with H+ and H2O produce O2. This process depletes pre-existing H+ and inhibits glycolysis LA production to cut off acidic TME source, and uproots their actions in reshaping cancer immunosuppression, e.g., removing the polarization impetus toward non-inflammatory M2 ones, addressing both symptoms and root causes of cytotoxic T lymphocytes and PD1+ T cells inactivation, etc. The cancer immunosuppression uprooting encourages the anti-tumor efficacy of cancer calcification and intratumoral H2O2 accumulation in the immune nanoregulators especially after anti-CD105-mediated active targeting accumulation. Collectively, this work presents a solution to uproot LA and non-inflammatory macrophages-induced cancer immunosuppression.
Keywords: acidic tumor microenvironment attenuation; anaerobic glycolysis regulation; lactic acid‐associated cancer immunosuppression uprooting; multichannel immune nanoregulators; non‐inflammatory macrophages.
© 2025 Wiley‐VCH GmbH.
References
-
- Y. Kato, S. Ozawa, C. Miyamoto, Y. Maehata, A. Suzuki, T. Maeda, Y. Baba, Cancer Cell Int. 2013, 13, 89.
-
- X. Dong, H. Liu, C. Fang, Y. Zhang, Q. Yang, H. Wang, X. Li, K. Zhang, Biomaterials 2024, 311, 122662.
-
- O. Elhanani, R. Ben‐Uri, L. Keren, Cancer Cell 2023, 41, 404.
-
- M. Z. Jin, W. L. Jin, Signal Transduct. Target. Ther. 2020, 5, 166.
-
- S. Walenta, M. Wetterling, M. Lehrke, G. Schwickert, K. Sundfor, E. K. Rofstad, W. Mueller‐Klieser, Cancer Res. 2000, 60, 916.